Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes.

Miro1 accumulation in skeletal muscle is linked to insulin resistance in patients with obesity and T2D, as shown in both humans and mouse models.

• Why it matters: Understanding mechanisms of skeletal muscle insulin resistance is crucial for developing targeted treatments for T2D, yet the role of mitochondrial dynamics remains unclear.
• What they did: Researchers examined Miro1 levels in patients and mouse models, demonstrating its accumulation due to impaired insulin-AKT interaction, and tested effects of exercise and Miro1 deletion.
• The result: Exercise reduces Miro1 accumulation and improves insulin sensitivity, while muscle-specific Miro1 deletion enhances oxidative capacity and insulin responsiveness, highlighting Miro1 as a potential therapeutic target.